1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow B-Cell Pediatric ALL: new trials by email Literature Review of B-Cell Pediatric ALL trials Research Report on B-Cell Pediatric ALL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma Moxetumomab Pasudotox - B-Cell Pediatric ALL | Phase 2 | Terminated | MedImmune LLC | 37 | 2014-08-01 | 2017-04-06 |
Leukemia, B-Cell (1) · Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1)
immunotoxin HA22 (1)
MedImmune LLC (1)
Australia (1) · Canada (1) · France (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)